Frazier Lifesciences Acquisition
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$138,378.
Cash Flow
| 2021 | -138.37K | 0 | 0 |
|---|
FLAC Cash Flow Statement (2021 – 2021)
| 2021 | |
|---|---|
Cash at beginning of period | 1.36M |
Operating activities | |
Net income | 4.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 0 |
Stock-based compensation expense | 0 |
| Deferred income tax benefit | 0 |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | 0 |
Inventories | 0 |
Accounts payable | 4.84K |
Cash generated by operating activities | -138.37K |
Investing activities | |
Purchases Of Investments | 0 |
Investments In Property Plant And Equipment | 0 |
Acquisitions Net | 0 |
Cash generated by investing activities | 0 |
Financing activities | |
Common Stock Issued | 0 |
Payments for dividends | 0 |
Repurchases of common stock | 0 |
Repayments of term debt | 0 |
Cash used in financing activities | 0 |
Net Change In Cash | -138.37K |
Cash at end of period | 1.22M |
| Data source |